KYMR Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2024-04-24 | 2023 | Nello Mainolfi, Ph.D. Founder, President and Chief Executive Officer | 640,000 | 0 | 0 | 422,400 | 13,200 | 9,670,542 |
| 2024-04-24 | 2023 | Jeremy Chadwick, Ph.D. Chief Operating Officer | 295,385 | 0 | 987,990 | 117,830 | 11,055 | 5,001,049 |
| 2024-04-24 | 2023 | Ellen Chiniara, J.D. Chief Legal Officer | 433,327 | 0 | 931,500 | 190,351 | 13,200 | 4,962,993 |
| 2024-04-24 | 2021 | Jared Gollob, M.D. Chief Medical Officer | 432,635 | 0 | 0 | 224,120 | 11,600 | 3,500,801 |
| 2024-04-24 | 2022 | Jared Gollob, M.D. Chief Medical Officer | 460,006 | 0 | 485,478 | 165,602 | 12,200 | 2,765,015 |
| 2024-04-24 | 2023 | Jared Gollob, M.D. Chief Medical Officer | 480,000 | 0 | 601,313 | 230,400 | 13,200 | 3,474,154 |
| 2024-04-24 | 2021 | Bruce Jacobs, CFA, MBA Chief Financial Officer | 415,539 | 0 | 0 | 207,000 | 11,600 | 4,599,562 |
| 2024-04-24 | 2022 | Bruce Jacobs, CFA, MBA Chief Financial Officer | 441,738 | 0 | 512,449 | 194,365 | 12,200 | 2,893,316 |
| 2024-04-24 | 2023 | Bruce Jacobs, CFA, MBA Chief Financial Officer | 470,000 | 0 | 761,663 | 188,000 | 13,200 | 4,155,156 |
| 2024-04-24 | 2021 | Nello Mainolfi, Ph.D. Founder, President and Chief Executive Officer | 570,582 | 0 | 0 | 369,525 | 11,600 | 11,573,374 |
| 2024-04-24 | 2022 | Nello Mainolfi, Ph.D. Founder, President and Chief Executive Officer | 600,000 | 0 | 0 | 363,000 | 12,200 | 6,926,645 |
| 2023-04-27 | 2020 | Nello Mainolfi, Ph.D. Founder, President and Chief Executive Officer | 453,619 | 0 | 0 | 379,000 | 0 | 3,678,001 |
| 2023-04-27 | 2022 | Nello Mainolfi, Ph.D. Founder, President and Chief Executive Officer | 600,000 | 0 | 0 | 363,000 | 12,200 | 6,926,645 |
| 2023-04-27 | 2021 | Nello Mainolfi, Ph.D. Founder, President and Chief Executive Officer | 570,582 | 0 | 0 | 369,525 | 11,600 | 11,573,374 |
| 2023-04-27 | 2022 | Bruce Jacobs, CFA, MBA Chief Financial Officer | 441,738 | 0 | 512,449 | 194,365 | 12,200 | 2,893,316 |
| 2023-04-27 | 2021 | Bruce Jacobs, CFA, MBA Chief Financial Officer | 415,539 | 0 | 0 | 207,000 | 11,600 | 4,599,562 |
| 2023-04-27 | 2020 | Bruce Jacobs, CFA, MBA Chief Financial Officer | 369,020 | 0 | 0 | 197,000 | 0 | 1,262,902 |
| 2023-04-27 | 2022 | Jared Gollob, M.D. Chief Medical Officer | 460,006 | 0 | 485,478 | 165,602 | 12,200 | 2,765,015 |
| 2023-04-27 | 2021 | Jared Gollob, M.D. Chief Medical Officer | 432,635 | 0 | 0 | 224,120 | 11,600 | 3,500,801 |
| 2023-04-27 | 2020 | Jared Gollob, M.D. Chief Medical Officer | 383,210 | 0 | 0 | 194,000 | 0 | 1,452,716 |
| 2023-04-27 | 2022 | Elaine Caughey, MBA Chief Business Officer | 403,300 | 0 | 269,710 | 112,924 | 12,200 | 1,684,511 |
| 2023-04-27 | 2021 | Elaine Caughey, MBA Chief Business Officer | 199,231 | 0 | 0 | 101,735 | 7,969 | 3,129,295 |
| 2022-04-29 | 2021 | Jared Gollob, M.D. Chief Medical Officer | 432,635 | 0 | 0 | 244,120 | 0 | 3,489,200 |
| 2022-04-29 | 2019 | Bruce Jacobs, CFA, MBA Chief Financial Officer | 172,615 | 0 | 0 | 59,132 | 0 | 679,283 |
| 2022-04-29 | 2020 | Bruce Jacobs, CFA, MBA Chief Financial Officer | 369,020 | 0 | 0 | 197,000 | 0 | 1,262,902 |
| 2022-04-29 | 2021 | Bruce Jacobs, CFA, MBA Chief Financial Officer | 415,539 | 0 | 0 | 207,000 | 0 | 4,587,962 |
| 2022-04-29 | 2019 | Nello Mainolfi, Ph.D. Founder, President and Chief Executive Officer | 362,472 | 0 | 0 | 142,061 | 0 | 1,808,732 |
| 2022-04-29 | 2020 | Nello Mainolfi, Ph.D. Founder, President and Chief Executive Officer | 453,619 | 0 | 0 | 379,000 | 0 | 3,678,001 |
| 2022-04-29 | 2020 | Richard Chesworth, Ph.D. Former Chief Scientific Officer | 144,946 | 0 | 0 | 60,000 | 0 | 4,534,243 |
| 2022-04-29 | 2021 | Richard Chesworth, Ph.D. Former Chief Scientific Officer | 314,046 | 0 | 0 | 0 | 74,423 | 2,087,937 |
| 2022-04-29 | 2021 | Elaine Caughey, MBA | 199,231 | 0 | 0 | 101,735 | 0 | 3,121,325 |
| 2022-04-29 | 2021 | Nello Mainolfi, Ph.D. Founder, President and Chief Executive Officer | 570,582 | 0 | 0 | 369,525 | 0 | 11,561,774 |
| 2022-04-29 | 2019 | Jared Gollob, M.D. Chief Medical Officer | 344,908 | 0 | 0 | 113,383 | 0 | 688,199 |
| 2022-04-29 | 2020 | Jared Gollob, M.D. Chief Medical Officer | 383,210 | 0 | 0 | 194,000 | 0 | 1,452,716 |
| 2021-04-30 | 2020 | Nello Mainolfi, Ph.D. Founder, President and Chief Executive Officer | 453,619 | 0 | 0 | 379,000 | 0 | 3,678,001 |
| 2021-04-30 | 2019 | Nello Mainolfi, Ph.D. Founder, President and Chief Executive Officer | 362,472 | 0 | 0 | 142,061 | 0 | 1,808,732 |
| 2021-04-30 | 2020 | Richard Chesworth, Ph.D. | 144,946 | 0 | 0 | 60,000 | 0 | 4,534,243 |
| 2021-04-30 | 2020 | Jared Gollob, M.D. Chief Medical Officer | 383,210 | 0 | 0 | 194,000 | 0 | 1,452,716 |
| 2021-04-30 | 2019 | Jared Gollob, M.D. Chief Medical Officer | 344,908 | 0 | 0 | 113,383 | 0 | 688,199 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
